BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8395150)

  • 1. Calcium channel types at the neuromuscular junction.
    Wray D; Porter V
    Ann N Y Acad Sci; 1993 Jun; 681():356-67. PubMed ID: 8395150
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibody specificities in Lambert-Eaton myasthenic syndrome.
    Lang B; Johnston I; Leys K; Elrington G; Marqueze B; Leveque C; Martin-Moutot N; Seagar M; Hoshino T; Takahashi M
    Ann N Y Acad Sci; 1993 Jun; 681():382-93. PubMed ID: 8395152
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic sites of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
    Takamori M; Iwasa K; Komai K
    Ann N Y Acad Sci; 1998 May; 841():625-35. PubMed ID: 9668306
    [No Abstract]   [Full Text] [Related]  

  • 4. Mammalian neuromuscular transmission blocked by funnel web toxin.
    Protti DA; Sanchez VA; Cherksey BD; Sugimori M; Llinás R; Uchitel OD
    Ann N Y Acad Sci; 1993 Jun; 681():405-7. PubMed ID: 8395156
    [No Abstract]   [Full Text] [Related]  

  • 5. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 1) The molecular structure of calcium channel and immunology].
    Komai K; Iwasa K; Takamori M
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):678-84. PubMed ID: 9627477
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between neuromuscular diseases and cancers].
    Takamori M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1841-51. PubMed ID: 10581772
    [No Abstract]   [Full Text] [Related]  

  • 7. Lambert-Eaton syndrome IgG inhibits dihydropyridine-sensitive, slowly inactivating calcium channels in bovine adrenal chromaffin cells.
    Blandino JK; Kim YI
    Ann N Y Acad Sci; 1993 Jun; 681():394-7. PubMed ID: 8395153
    [No Abstract]   [Full Text] [Related]  

  • 8. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
    Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
    Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
    [No Abstract]   [Full Text] [Related]  

  • 9. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
    Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
    Giovannini F; Sher E; Webster R; Boot J; Lang B
    Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative potencies of metal ions on transmitter release at mouse motor nerve terminals.
    Porter VA; Wray D
    Br J Pharmacol; 1996 May; 118(1):27-32. PubMed ID: 8733572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.
    Leys K; Lang B; Vincent A; Newsom-Davis J
    Lancet; 1989 Nov; 2(8671):1107. PubMed ID: 2572837
    [No Abstract]   [Full Text] [Related]  

  • 16. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
    Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y
    J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lambert-Eaton myasthenic syndrome].
    Takamori M
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1903-11. PubMed ID: 9788200
    [No Abstract]   [Full Text] [Related]  

  • 18. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lambert-Eaton syndrome without calcium channel autoantibodies].
    Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
    Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lambert Eaton myasthenic syndrome.
    Petty R
    Pract Neurol; 2007 Aug; 7(4):265-7. PubMed ID: 17636143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.